Novartis Q2 EPS $1.83 Beats $1.66 Estimate, Sales $13.62B Beat $13.17B Estimate
Portfolio Pulse from Benzinga Newsdesk
Novartis (NYSE:NVS) reported Q2 earnings of $1.83 per share, beating the analyst consensus estimate of $1.66 by 10.24%. This is a 17.31% increase from the same period last year. The company also reported quarterly sales of $13.62 billion, beating the analyst consensus estimate of $13.17 billion by 3.42%. This is a 6.56% increase from the same period last year.
July 18, 2023 | 6:03 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Novartis reported better than expected Q2 earnings and sales, which could positively impact its stock price.
Novartis reported higher than expected earnings and sales for Q2, which is typically a positive signal for investors and could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100